USA - NASDAQ:INNV - US45784A1043 - Common Stock
Taking everything into account, INNV scores 3 out of 10 in our fundamental rating. INNV was compared to 101 industry peers in the Health Care Providers & Services industry. While INNV seems to be doing ok healthwise, there are quite some concerns on its profitability. INNV is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -5.75% | ||
ROE | -12.9% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 18% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.28 | ||
Debt/FCF | 2.72 | ||
Altman-Z | 2.66 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.07 | ||
Quick Ratio | 1.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 96.47 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 25.09 | ||
EV/EBITDA | 177.18 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:INNV (9/23/2025, 12:30:12 PM)
4.92
-0.03 (-0.61%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 96.47 | ||
P/S | 0.78 | ||
P/FCF | 25.09 | ||
P/OCF | 20.31 | ||
P/B | 2.84 | ||
P/tB | 7.49 | ||
EV/EBITDA | 177.18 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -5.75% | ||
ROE | -12.9% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 18% | ||
FCFM | 3.12% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.28 | ||
Debt/FCF | 2.72 | ||
Debt/EBITDA | 19.32 | ||
Cap/Depr | 32.1% | ||
Cap/Sales | 0.73% | ||
Interest Coverage | N/A | ||
Cash Conversion | 976.7% | ||
Profit Quality | N/A | ||
Current Ratio | 1.07 | ||
Quick Ratio | 1.07 | ||
Altman-Z | 2.66 |